fda_483 · inspection_citation · high

Pine Pharmaceuticals LLC -- FDA 483: 2 observations (2025-11-14)

Event date
2025-11-14 00:00:00Z
Observed
2026-07-12 22:31:32Z
Source ID
3010943533-2025-11-14-190690
Payload hash
be6fbd8a1f41c84ee6903dd9

Summary

Observation 2: Procedures designed to prevent microbiological contamination of drug products purporting to be sterile are not followed. Specificall y, 1 ) On 11 /4/2025, during the aseptic repackaging...

Informational only. Not legal, financial, or medical advice.